U.S. presidential contest
takes center stage for investors
Send a link to a friend
[September 24, 2016]
By Noel Randewich
SAN FRANCISCO (Reuters) - Who becomes the
next U.S. president will be a primary focus for Wall Street next week
and beyond, starting on Monday with the first debate between candidates
Hillary Clinton and Donald Trump.
While the White House race has so far had little discernible effect on
the market, that may soon change as polls show a tightening race.
Clinton's once-comfortable lead in opinion polls has evaporated, and
with just over six weeks until Election Day, some investors see a
toss-up contest creating volatility in certain sectors, including health
insurers, drugmakers and industrials.
Also, many on Wall Street worry about the uncertainty of what Trump
would do as president, as well as his sometimes contradictory proposals
at odds with mainstream Republicans, such as his protectionist stance on
international trade.
Some investors believe U.S. equities are likely to edge higher next week
after the Federal Reserve on Wednesday left interest rates unchanged.
The S&P 500 has gained 6 percent in 2016 and is about 1 percent short of
its record high set in August.
"We're probably looking at a modestly positive week pushing the high end
of the S&P 500, unless something comes out of the debate that spells
real success for Trump," said Phil Blancato, chief executive of
Ladenburg Thalmann Asset Management in New York. "The market seems to
favoring the 'known' of Hilary rather than the 'unknown' of Trump."
In a recent report, Wells Fargo said a Clinton presidency with a divided
U.S. Congress would have a "neutral" impact on financial markets. A
Trump victory and a divided Congress would have a "slightly negative"
market impact, Wells Fargo said.
So far, the election has been too close to call and too far away to
trade specific stocks, some investors said.
[to top of second column] |
A Wall Street sign is pictured outside the New York Stock Exchange
in New York, October 28, 2013. REUTERS/Carlo Allegri/File Photo
Still, many view a Clinton presidency as broadly negative for pharmaceutical
companies because of criticisms she has made about high drug prices. Clinton
frequently said during the primary that she would fight pharmaceutical
companies, part of an attempt to counter criticism that she was too closely tied
to the insurance industry.
Trump's disapproval of free trade agreements suggests that industrial companies
and other major exporters might suffer should he become president, said David
Schiegoleit, managing director at the Private Client Reserve at U.S. Bank.
With Trump vowing to repeal the Affordable Care Act and Clinton promising to
build on it, health insurance stocks could swing if the debate produces a clear
winner, Convergex market strategist Nicholas Colas wrote in a note on Friday.
Health insurers have been big winners since President Barack Obama signed his
healthcare overhaul in 2010. UnitedHealth Group <UNH.N> has jumped 325 percent,
Aetna <AET.N> is 234 percent higher and Cigna <CI.N> has risen 257 percent.
During the same time, the S&P 500 rose 85 percent.
(Reporting by Noel Randewich, additional reporting by Chuck Mikolajczak in New
York; Editing by Dan Burns and Meredith Mazzilli)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|